Published in Infect Immun on September 08, 2015
The Role of Staphylococcus aureus Virulence Factors in Skin Infection and Their Potential as Vaccine Antigens. Pathogens (2016) 0.79
IL-10 Plays Opposing Roles during Staphylococcus aureus Systemic and Localized Infections. J Immunol (2017) 0.75
Impact of Staphylococcus aureus USA300 Colonization and Skin Infections on Systemic Immune Responses in Humans. J Immunol (2016) 0.75
Innate Immune Memory Contributes to Host Defense Against Recurrent Skin and Skin Structure Infections Caused by Methicillin-Resistant Staphylococcus aureus. Infect Immun (2016) 0.75
Contribution of Staphylococcus aureus Coagulases and Clumping Factor A to Abscess Formation in a Rabbit Model of Skin and Soft Tissue Infection. PLoS One (2016) 0.75
Pulmonary IL-17+ Lymphocytes Increase During Pneumocystis murina Infection But Are Not Required for Clearance of Pneumocystis. Infect Immun (2017) 0.75
Yin and yang of interleukin-17 in host immunity to infection. F1000Res (2017) 0.75
Invasive methicillin-resistant Staphylococcus aureus infections in the United States. JAMA (2007) 26.98
Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis (2004) 20.99
Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med (2006) 13.74
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev (2010) 9.82
Community-associated meticillin-resistant Staphylococcus aureus. Lancet (2010) 9.07
IL-22 increases the innate immunity of tissues. Immunity (2004) 8.30
Is Panton-Valentine leukocidin the major virulence determinant in community-associated methicillin-resistant Staphylococcus aureus disease? J Infect Dis (2006) 8.17
Either a Th17 or a Th1 effector response can drive autoimmunity: conditions of disease induction affect dominant effector category. J Exp Med (2008) 5.25
Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol (2009) 4.69
Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol (2006) 4.60
National burden of invasive methicillin-resistant Staphylococcus aureus infections, United States, 2011. JAMA Intern Med (2013) 4.21
Modulation of granulocyte survival and programmed cell death by cytokines and bacterial products. Blood (1992) 4.11
Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest (2009) 4.10
IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest (2010) 3.40
The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol (2007) 3.06
Biology of interleukin-22. Semin Immunopathol (2010) 2.92
Animal models of sepsis and sepsis-induced kidney injury. J Clin Invest (2009) 2.71
Direct continuous method for monitoring biofilm infection in a mouse model. Infect Immun (2003) 2.35
Immunity against Staphylococcus aureus cutaneous infections. Nat Rev Immunol (2011) 2.20
Predictors of mortality in Staphylococcus aureus Bacteremia. Clin Microbiol Rev (2012) 2.18
Serious infections caused by methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2010) 2.13
Complicated skin and soft tissue infection. J Antimicrob Chemother (2010) 2.12
Th1 and Th17 cells: adversaries and collaborators. Ann N Y Acad Sci (2010) 2.08
Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey. Clin Infect Dis (2012) 1.97
Epidemiology of Staphylococcus aureus blood and skin and soft tissue infections in the US military health system, 2005-2010. JAMA (2012) 1.81
Interferon-gamma activation of polymorphonuclear neutrophil function. Immunology (2004) 1.77
NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults. Vaccine (2012) 1.77
Molecular differentiation of historic phage-type 80/81 and contemporary epidemic Staphylococcus aureus. Proc Natl Acad Sci U S A (2011) 1.70
Community-associated methicillin-resistant Staphylococcus aureus skin and soft tissue infections in men who have sex with men in New York City. Arch Intern Med (2007) 1.65
Interleukin-10 counterregulates proinflammatory cytokine-induced inhibition of neutrophil apoptosis during severe sepsis. Blood (1997) 1.58
IL-4 and IL-13 negatively regulate TNF-alpha- and IFN-gamma-induced beta-defensin expression through STAT-6, suppressor of cytokine signaling (SOCS)-1, and SOCS-3. J Immunol (2007) 1.55
A play in four acts: Staphylococcus aureus abscess formation. Trends Microbiol (2011) 1.53
NorB, an efflux pump in Staphylococcus aureus strain MW2, contributes to bacterial fitness in abscesses. J Bacteriol (2008) 1.47
Chronic granulomatous disease: a review of the infectious and inflammatory complications. Clin Mol Allergy (2011) 1.42
Current concepts in antimicrobial therapy against select gram-positive organisms: methicillin-resistant Staphylococcus aureus, penicillin-resistant pneumococci, and vancomycin-resistant enterococci. Mayo Clin Proc (2011) 1.33
The IL-20 subfamily of cytokines--from host defence to tissue homeostasis. Nat Rev Immunol (2014) 1.22
Community-onset methicillin-resistant Staphylococcus aureus in an urban HIV clinic. HIV Med (2006) 1.22
Abscess formation and alpha-hemolysin induced toxicity in a mouse model of Staphylococcus aureus peritoneal infection. Infect Immun (2012) 1.16
Induction of innate lymphoid cell-derived interleukin-22 by the transcription factor STAT3 mediates protection against intestinal infection. Immunity (2014) 1.14
Effects of gamma-interferon on human neutrophils: protection from deterioration on storage. Blood (1992) 1.09
Concurrent epidemics of skin and soft tissue infection and bloodstream infection due to community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2012) 1.06
Tissue-specific patterning of host innate immune responses by Staphylococcus aureus α-toxin. J Innate Immun (2014) 1.06
Protective immunity against recurrent Staphylococcus aureus skin infection requires antibody and interleukin-17A. Infect Immun (2014) 1.05
Staphylococcus aureus infection of mice expands a population of memory γδ T cells that are protective against subsequent infection. J Immunol (2014) 1.05
Deficiency of IL-22 contributes to a chronic inflammatory disease: pathogenetic mechanisms in acne inversa. J Immunol (2010) 1.04
Gamma interferon enhances the killing of Staphylococcus aureus by human neutrophils. J Gen Microbiol (1988) 1.02
Expression of interleukin-17RC protein in normal human tissues. Int Arch Med (2008) 1.01
Mechanical and metabolic injury to the skin barrier leads to increased expression of murine β-defensin-1, -3, and -14. J Invest Dermatol (2010) 0.99
Comparison of interferon-gamma, granulocyte colony-stimulating factor, and granulocyte-macrophage colony-stimulating factor for priming leukocyte-mediated hyphal damage of opportunistic fungal pathogens. J Infect Dis (1999) 0.98
Staphylococcal-associated molecular patterns enhance expression of immune defense genes induced by IL-17 in mammary epithelial cells. Cytokine (2011) 0.97
Vitamin D analog calcipotriol suppresses the Th17 cytokine-induced proinflammatory S100 "alarmins" psoriasin (S100A7) and koebnerisin (S100A15) in psoriasis. J Invest Dermatol (2012) 0.95
A series of skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus in HIV-infected patients. J Acquir Immune Defic Syndr (2006) 0.94
Antibiotic susceptibility survey of blood-borne MRSA isolates in Japan from 2008 through 2011. J Infect Chemother (2014) 0.93
Epicutaneous model of community-acquired Staphylococcus aureus skin infections. Infect Immun (2013) 0.92
IL-17 and IL-22 enhance skin inflammation by stimulating the secretion of IL-1β by keratinocytes via the ROS-NLRP3-caspase-1 pathway. Int Immunol (2011) 0.91
Mechanisms of NDV-3 vaccine efficacy in MRSA skin versus invasive infection. Proc Natl Acad Sci U S A (2014) 0.91
IL-22 promotes fibroblast-mediated wound repair in the skin. J Invest Dermatol (2012) 0.91
In vivo activation of peripheral blood polymorphonuclear neutrophils by gamma interferon results in enhanced fungal killing. Infect Immun (1989) 0.90
Bacteriology of hidradenitis suppurativa - which antibiotics are the treatment of choice? Acta Derm Venereol (2014) 0.87
Hospitalist perspective on the treatment of skin and soft tissue infections. Mayo Clin Proc (2014) 0.87
IL-17A suppresses the expression of bone resorption-related proteinases and osteoclast differentiation via IL-17RA or IL-17RC receptors in RAW264.7 cells. Biochimie (2010) 0.85
Interferon-gamma effects on activities of gentamicin and vancomycin against Enterococcus faecalis resistant to the drugs: an in vitro study with human neutrophils. Int J Antimicrob Agents (1999) 0.83
Recombinant interferon-gamma preserves human granulocyte bactericidal and chemoluminescence activities. J Infect Dis (1993) 0.83
Ceftaroline is active against heteroresistant methicillin-resistant Staphylococcus aureus clinical strains despite associated mutational mechanisms and intermediate levels of resistance. Antimicrob Agents Chemother (2014) 0.82
Ceftaroline-heteroresistant Staphylococcus aureus. Antimicrob Agents Chemother (2014) 0.81
22 again: IL-22 as a risk gene and important mediator in psoriasis. J Invest Dermatol (2014) 0.78
Bactericidal activity of neutrophils with reduced oxidative burst from adults with bronchiectasis. APMIS (2009) 0.78